{"schema_version":"secwatch.filing_event.v1","accession":"0001564590-22-038025","form_type":"8-K","ticker":"ACHV","cik":"0000949858","company_name":"ACHIEVE LIFE SCIENCES, INC.","filed_at":"2022-11-18T23:59:59+00:00","discovered_at":"2026-05-14T18:03:54.132934+00:00","generated_at":"2026-06-21T16:20:35.911168+00:00","sec_items":["1.01","3.02","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Achieve Life Sciences raises $18.9M in private placement of units at $4.625/unit","bullets":["Gross proceeds of ~$18.9M from sale of 4,093,141 units at $4.625/unit; each unit consists of 2 common shares and a warrant to buy one share.","Pricing represents an 8.6% premium to prior day's closing price ($2.3125 per common share).","Net proceeds ~$17.9M after expenses; funds operations into late 2023; used for clinical R&D and working capital.","Warrants exercisable at $4.50/share for 7 years, beginning 6 months after close; callable under certain conditions.","Placement includes new life sciences fund, management participation, and existing investors; Lake Street Capital Markets as exclusive placement agent."],"urls":{"canonical":"https://secwatch.observer/filing/0001564590-22-038025","json":"https://secwatch.observer/filing/0001564590-22-038025.json","markdown":"https://secwatch.observer/filing/0001564590-22-038025.md","text":"https://secwatch.observer/filing/0001564590-22-038025.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/949858/000156459022038025/0001564590-22-038025-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/949858/000156459022038025/achv-8k_20221114.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-21T16:20:35.911168+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"42e5205c970fceff9ea7a0ea67e9db170564d896","claim":"ACHIEVE LIFE SCIENCES, INC. entered into Subscription Agreements with certain accredited investors valued at approximately $18.9 million (effective 2022-11-14).","evidence_excerpt":"On November 14, 2022, Achieve Life Sciences, Inc., a Delaware corporation (the “ Company ”), entered into subscription agreements (the “ Subscription Agreements ”) with certain accredited investors (the “ Purchasers ”) pursuant to which the Company agreed to issue and sell to the Purchasers in a private placement 4,093,141 units (each, a “ Unit ”), each consisting of (i) two shares of the Company’s common stock, par value $0.001 per share (the “ Common Stock ”), and (ii) a warrant to purchase one share of Common Stock (the “ Warrants ”), at an offering price of $4.625 per Unit, for aggregate gross proceeds of approximately $18.9 million (the “ Offering ”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/949858/000156459022038025/0001564590-22-038025-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"certain accredited investors"},{"label":"Value","value":"approximately $18.9 million"},{"label":"Effective","value":"2022-11-14"}],"fact_type":"material_agreement"},{"claim_id":"49c746e694ac24afb13255d956ba129e63ab3db4","claim":"ACHIEVE LIFE SCIENCES, INC. entered into Placement Agent Agreement with Lake Street Capital Markets, LLC.","evidence_excerpt":"Lake Street Capital Markets, LLC (the “ Placement Agent ”), acted as the exclusive placement agent for the Offering and, pursuant to the engagement agreement between the Company and the Placement Agent (the “ Placement Agent Agreement ”), will receive a cash commission equal to 5% of the gross proceeds from the sale of the Units.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/949858/000156459022038025/0001564590-22-038025-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"underwriting"},{"label":"Counterparty","value":"Lake Street Capital Markets, LLC"}],"fact_type":"material_agreement"},{"claim_id":"8f466cc168d3c39f2ea33434a940d2561d4daaca","claim":"ACHIEVE LIFE SCIENCES, INC. entered into Registration Rights Agreement with the Purchasers (effective 2022-11-18).","evidence_excerpt":"Pursuant to the Subscription Agreements, on November 18, 2022, the Company entered into a registration rights agreement (the “ Registration Rights Agreement ”) with the Purchasers, under which the Company is required to file a registration statement within 60 days following the final closing date of the Offering (the “ Registration Statement ”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/949858/000156459022038025/0001564590-22-038025-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"the Purchasers"},{"label":"Effective","value":"2022-11-18"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}